Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
Authors:
- 1 June 2014
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 40 (3) , 169-175
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2012
- Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled TrialsPLOS Medicine, 2012
- Licensing drugs for diabetesBMJ, 2010
- Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes MellitusArchives of internal medicine (1960), 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Some answers, more controversy, from UKPDSThe Lancet, 1998